HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,605-2,616 of 4,505
Behavioral study icon
CompletedNCT01891929

Cognitive Remediation and Sheltered Employment in Schizophrenia

Official study title

Specific Cognitive Remediation for Schizophrenia (RECOS) and Sheltered Employment: a Multicentre Controlled Randomized Trial.

This study has finished and is no longer accepting participants.

Multiple locations, including Bron
SchizophreniaBehavioural studyAges 18–50
Countries
France
Sponsor
Hôpital le Vinatier
Behavioral study icon
CompletedNCT01781923

Cognitive Remediation in 22q11DS

Official study title

A Remediation Program for Children at High-Risk of Schizophrenia: 22q11.2 Deletion Syndrome

This study has finished and is no longer accepting participants.

In Durham
SchizophreniaBehavioural studyAges 11–17
Countries
United States
Sponsor
Duke University
Behavioral study icon
CompletedNCT01078129

Cognitive Remediation Therapy and Schizophrenia

Official study title

Efficacy of Hierarchized Computer-assisted Cognitive Remediation Therapy in Schizophrenia

This study has finished and is no longer accepting participants.

In Bron
SchizophreniaBehavioural studyAges 18–40
Countries
France
Sponsor
Hôpital le Vinatier
Behavioral study icon
CompletedNCT03695614

Cognitive Remediation Therapy for people with Late-Life Schizophrenia

What is this study about?

Researchers studied training for memory, attention and thinking skills to find out how it affected memory, attention and other thinking skills in older adults with schizophrenia.

This study has finished and is no longer accepting participants.

In Toronto
SchizophreniaInterventional studyAges 55+
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Drug study icon
CompletedNCT01213836

Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in people with Stable Schizophrenia

Official study title

A Phase IV Prospective, Double-blind, Double-dummy, Randomised, Crossover Study to Assess the Impact on Daily Cognitive Functioning of Quetiapine Fumarate Immediate Release (Seroquel IR®) Dosed Twice Daily and Quetiapine Fumarate Extended Release (Seroquel XR®) Dosed Once Daily in the Evening in Patients With Stable Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Vienna
SchizophreniaMedication studyAges 18–50
Countries
Austria, Denmark, Germany, + 2 others
Sponsor
AstraZeneca
Drug study icon
CompletedNCT02360319

Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics

Official study title

A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Tucson
SchizophreniaMedication studyAges 18–35
Countries
United States
Sponsor
Vanguard Research Group
Drug study icon
CompletedNCT03807882

Comparison of Maintenance ECT Versus Clozapine in Treatment-resistant Schizophrenia

Official study title

Comparison of Maintenance ECT Versus Clozapine on Psychopathology and Cerebral Hemodynamics in Treatment-resistant Schizophrenia: A Randomized Controlled Trial

This study has finished and is no longer accepting participants.

In Bhubaneswar
SchizophreniaMedication studyAges 18–60
Countries
India
Sponsor
All India Institute of Medical Sciences, Bhubaneswar

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.